Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.

Gladwin MT, Gordeuk VR, Desai PC, Minniti C, Novelli EM, Morris CR, Ataga KI, De Castro L, Curtis SA, El Rassi F, Ford HJ, Harrington T, Klings ES, Lanzkron S, Liles D, Little J, Nero A, Smith W, Taylor JG 6th, Baptiste A, Hagar W, Kanter J, Kinzie A, Martin T, Rafique A, Telen MJ, Lalama CM, Kato GJ, Abebe KZ

Open source

DOI: 10.1016/s2352-3026(24)00045-0
Published: 2024 May
Container: The Lancet. Haematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-3026-24-00045-0,
  title = {Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.},
  author = {Gladwin MT and Gordeuk VR and Desai PC and Minniti C and Novelli EM and Morris CR and Ataga KI and De Castro L and Curtis SA and El Rassi F and Ford HJ and Harrington T and Klings ES and Lanzkron S and Liles D and Little J and Nero A and Smith W and Taylor JG 6th and Baptiste A and Hagar W and Kanter J and Kinzie A and Martin T and Rafique A and Telen MJ and Lalama CM and Kato GJ and Abebe KZ},
  year = {2024},
  journal = {The Lancet. Haematology},
  doi = {10.1016/s2352-3026(24)00045-0},
  url = {https://doi.org/10.1016/s2352-3026(24)00045-0}
}

RIS

TY  - JOUR
TI  - Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.
AU  - Gladwin MT
AU  - Gordeuk VR
AU  - Desai PC
AU  - Minniti C
AU  - Novelli EM
AU  - Morris CR
AU  - Ataga KI
AU  - De Castro L
AU  - Curtis SA
AU  - El Rassi F
AU  - Ford HJ
AU  - Harrington T
AU  - Klings ES
AU  - Lanzkron S
AU  - Liles D
AU  - Little J
AU  - Nero A
AU  - Smith W
AU  - Taylor JG 6th
AU  - Baptiste A
AU  - Hagar W
AU  - Kanter J
AU  - Kinzie A
AU  - Martin T
AU  - Rafique A
AU  - Telen MJ
AU  - Lalama CM
AU  - Kato GJ
AU  - Abebe KZ
PY  - 2024
JO  - The Lancet. Haematology
DO  - 10.1016/s2352-3026(24)00045-0
UR  - https://doi.org/10.1016/s2352-3026(24)00045-0
ER  -

APA

MT, G., VR, G., PC, D., C, M., EM, N., CR, M., KI, A., L, D. C., SA, C., F, E. R., HJ, F., T, H., ES, K., S, L., D, L., J, L., A, N., W, S., 6th, T. J., A, B., W, H., J, K., A, K., T, M., A, R., MJ, T., CM, L., GJ, K., & KZ, A. (2024). Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.. The Lancet. Haematology. https://doi.org/10.1016/s2352-3026(24)00045-0

Source records

pubmed · retrieved 2026-09-26T23:16:03.140Z